Chronic Myeloid Leukemia: Clinical Impact of BCR-ABL1 Mutations and Other Lesions Associated With Disease Progression

被引：41
|
作者：
Ernst, Thomas [1 ]
Hochhaus, Andreas [1 ]
机构：
[1] Univ Klinikum Jena, Klin Innere Med 2, Hamatol Onkol Abt, Jena, Germany
来源：
SEMINARS IN ONCOLOGY | 2012年 / 39卷 / 01期
关键词：
ABL KINASE DOMAIN; CHRONIC MYELOGENOUS LEUKEMIA; PHILADELPHIA-POSITIVE PATIENTS; GIMEMA WORKING PARTY; TYROSINE KINASE; BLAST CRISIS; IMATINIB MESYLATE; CHRONIC-PHASE; PATIENTS RESISTANT; POINT MUTATIONS;
D O I：
10.1053/j.seminoncol.2011.11.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：58 / 66
页数：9
相关论文
共 50 条
  • [1] Chronic Myeloid Leukemia: Beyond BCR-ABL1
    Zhou, Ting
    Medeiros, L. Jeffrey
    Hu, Shimin
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (06) : 435 - 445
  • [2] Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
    Soverini, Simona
    de Benedittis, Caterina
    Mancini, Manuela
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S120 - S128
  • [3] Chronic Myeloid Leukemia: Beyond BCR-ABL1
    Ting Zhou
    L. Jeffrey Medeiros
    Shimin Hu
    Current Hematologic Malignancy Reports, 2018, 13 : 435 - 445
  • [4] Incidence and clinical importance of BCR-ABL1 mutations in Iranian patients with chronic myeloid leukemia on imatinib
    Golale Rostami
    Mohammad Hamid
    Majid Yaran
    Mohsen Khani
    Morteza Karimipoor
    Journal of Human Genetics, 2015, 60 : 253 - 258
  • [5] Incidence and clinical importance of BCR-ABL1 mutations in Iranian patients with chronic myeloid leukemia on imatinib
    Rostami, Golale
    Hamid, Mohammad
    Yaran, Majid
    Khani, Mohsen
    Karimipoor, Morteza
    JOURNAL OF HUMAN GENETICS, 2015, 60 (05) : 253 - 258
  • [6] Reflexive Screening for BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia
    Langabeer, Stephen E.
    McCarron, Sarah L.
    Haslam, Karl
    Preston, Lisa
    CLINICAL LABORATORY, 2016, 62 (05) : 975 - 976
  • [7] STUDY OF MUTATIONS IN THE KINASE DOMAIN OF BCR-ABL1 BY NGS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Stuckey, Ruth
    Florido, Ortega Yanira
    Rodriguez, Lopez Juan Francisco
    Bilbao, Sieyro Cristina
    Gomez, Casares Maria Teresa
    HAEMATOLOGICA, 2020, 105 : 239 - 239
  • [8] Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia
    Krumbholz, Manuela
    Karl, Matthias
    Tauer, Josephine T.
    Thiede, Christian
    Rascher, Wolfgang
    Suttorp, Meinolf
    Metzler, Markus
    GENES CHROMOSOMES & CANCER, 2012, 51 (11): : 1045 - 1053
  • [9] A Novel BCR-ABL1 Degrader, Ubx-362, Can Overcome Resistance By BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia
    Lim, Ye Seul
    Jeong, Na-Rae
    Yoo, Sun-Mi
    Kim, Han Wool
    Lee, Song Hee
    Kim, Dong-Wook
    BLOOD, 2023, 142
  • [10] Emerging kinetics of BCR-ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure
    Shih, Lee-Yung
    Kuo, Ming-Chung
    Kuo, Ching-Yuan
    Lin, Tseng-Hsi
    Bai, Li-Yaun
    Chen, Tsai-Yun
    Wang, Ming-Chung
    Lin, Tung-Liang
    Lan, Yii-Jenq
    Chen, Chih-Cheng
    Yang, Youngsen
    Hsiao, Pei-Ching
    Lai, Chang-Liang
    Chang, Chia-Hui
    Lin, Tung-Huei
    LEUKEMIA RESEARCH, 2013, 37 (01) : 43 - 49
12345